“…However, the pharmacological development of puerarin is limited by its low water solubility and bioavailability (Ren et al, 2006). Thus, significant effort has been made to chemically or biologically modify the structure of puerarin to obtain novel puerarin derivatives with higher water solubility and biological activity (Li et al, 2004;Huang et al, 2008;Jiang et al, 2008;Yu et al, 2010;Ko et al, 2012). Previous studies have shown that transformation of flavonoid substances in the form of aglycon to glycosides improves not only their physical and chemical properties, such as water solubility, taste and sweetness but also their pharmacological activities, including circulation, metabolism, and concentration in body fluids (Lee et al, 1999;Kren et al, 2001;Daines et al, 2004;Blanchard et al, 2006;Hyung et al, 2006;Salas et al, 2007).…”